Skaana Management L.P. Novavax Inc Transaction History
Skaana Management L.P.
- $101 Million
- Q4 2024
A detailed history of Skaana Management L.P. transactions in Novavax Inc stock. As of the latest transaction made, Skaana Management L.P. holds 334,887 shares of NVAX stock, worth $2.68 Million. This represents 2.67% of its overall portfolio holdings.
Number of Shares
334,887
Previous 333,887
0.3%
Holding current value
$2.68 Million
Previous $4.22 Million
36.15%
% of portfolio
2.67%
Previous 3.23%
Shares
6 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$126 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$94.7 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$89.1 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$61.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$46.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $625M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...